Share

October 06, 2015; 85 (14) ArticleOpen Access

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

Sebastian Palmqvist, Henrik Zetterberg, Niklas Mattsson, Per Johansson, For the Alzheimer's Disease Neuroimaging Initiative, Lennart Minthon, Kaj Blennow, Mattias Olsson, For the Swedish BioFINDER study group, Oskar Hansson
First published September 9, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001991
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
6352

Share

Article Information

vol. 85 no. 14 1240-1249
DOI: 
https://doi.org/10.1212/WNL.0000000000001991
PubMed: 
26354982
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received February 4, 2015
  • Accepted in final form June 3, 2015
  • First Published September 9, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Sebastian Palmqvist, MD, PhD,
    2. Henrik Zetterberg, MD, PhD,
    3. Niklas Mattsson, MD, PhD,
    4. Per Johansson, MD, PhD;
    5. For the Alzheimer's Disease Neuroimaging Initiative,
    6. Lennart Minthon, MD, PhD,
    7. Kaj Blennow, MD, PhD,
    8. Mattias Olsson, PhD;
    9. For the Swedish BioFINDER study group and
    10. Oskar Hansson, MD, PhD
  1. Sebastian Palmqvist, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Henrik Zetterberg, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer's Disease, Senior Editor Alzheimer's & Dementia, Associate Editor

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) The Swedish Research Council (K2010-63P-21562-01-4, K2011-61X-20401-05-6); (2) Swedish State Support for Clinical Research (ALFGBG-144341)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Niklas Mattsson, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swedish Research Council, Sahlgrenska University Hospital, Sahlgrenska Academy, Goteborgs Lakaresallskap, Svenska Lakareskallskapet, Klinisk Biokemi i Norden, Carl-Bertil Laurells foundation.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Per Johansson, MD, PhD;
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. For the Alzheimer's Disease Neuroimaging Initiative,
  6. Lennart Minthon, MD, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Kaj Blennow, MD, PhD,
    8. Scientific Advisory Boards:

    1. Dr Blennow has served at advisory boards for Eli Lilly, IBL International, Roche Diagnostics.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Fujirebio Europe

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Novartis

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. The Research Council, Sweden (project # 14002), and LUA/ALF project, V?stra G?talandsregionen, Sweden (project # ALFGBG-11019)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The Torsten S?derberg Foundation at the royal Swedish Academy of Sciences, the Stiftelsen f?r Gamla Tj?narinnor, and Hj?rnfonden, Sweden.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Mattias Olsson, PhD;
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. For the Swedish BioFINDER study group and
  10. Oskar Hansson, MD, PhD
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The support is listed in the manuscript.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

    1. Authors' affiliations are provided at the end of the article.
    1. Correspondence to Dr. Palmqvist: sebastian.palmqvist{at}med.lu.se or Dr. Hansson: oskar.hansson{at}med.lu.se
    View Full Text

    Article usage

    Article usage: October 2015 to May 2020

    AbstractFullPdfSource
    Sep 201518822322Highwire
    Oct 20152745274783Highwire
    Oct 20150117pmc
    Nov 201540293165Highwire
    Nov 2015012964pmc
    Dec 201539665109Highwire
    Dec 201509258pmc
    Jan 201633586115Highwire
    Jan 201608247pmc
    Feb 201627277130Highwire
    Feb 20160111124pmc
    Mar 201622564105Highwire
    Mar 201608048pmc
    Apr 201613555117Highwire
    Apr 201608349pmc
    May 201613439106Highwire
    May 201605420pmc
    Jun 20161163065Highwire
    Jun 201605722pmc
    Jul 2016892678Highwire
    Jul 201605331pmc
    Aug 2016882859Highwire
    Aug 201604719pmc
    Sep 2016963567Highwire
    Sep 201606620pmc
    Oct 2016892581Highwire
    Oct 201606617pmc
    Nov 2016642767Highwire
    Nov 201607826pmc
    Dec 2016602049Highwire
    Dec 201604522pmc
    Jan 2017713156Highwire
    Jan 201708727pmc
    Feb 2017572462Highwire
    Feb 201707929pmc
    Mar 2017812659Highwire
    Mar 2017011835pmc
    Apr 2017633270Highwire
    Apr 2017255476pmc
    May 2017801486Highwire
    May 2017246682pmc
    Jun 2017342032Highwire
    Jun 2017246682pmc
    Jul 2017311819Highwire
    Jul 2017205372pmc
    Aug 2017332433Highwire
    Aug 2017216895pmc
    Sep 2017302669Highwire
    Sep 20172187110pmc
    Oct 2017642646Highwire
    Oct 201738121151pmc
    Nov 2017612556Highwire
    Nov 20172491120pmc
    Dec 2017193737Highwire
    Jan 2018437053Highwire
    Feb 2018222127Highwire
    Mar 2018264740Highwire
    Apr 2018334944Highwire
    Apr 2018155667pmc
    May 2018443933Highwire
    Jun 2018272755Highwire
    Jun 2018306678pmc
    Jul 2018355448Highwire
    Aug 2018233835Highwire
    Aug 2018258897pmc
    Sep 2018344346Highwire
    Oct 2018324660Highwire
    Nov 2018426991Highwire
    Dec 2018235835Highwire
    Jan 2019255167Highwire
    Feb 2019226238Highwire
    Mar 20194058153Highwire
    Apr 2019165357Highwire
    May 2019314961Highwire
    Jun 2019196262Highwire
    Jul 2019275669Highwire
    Aug 2019215583Highwire
    Sep 201974053Highwire
    Oct 2019296495Highwire
    Nov 2019306354Highwire
    Dec 2019483362Highwire
    Jan 2020213438Highwire
    Feb 2020156446Highwire
    Mar 2020236553Highwire
    Apr 2020164456Highwire

    Cited By...

    Disputes & Debates: Rapid online correspondence

    No comments have been published for this article.
    Comment

    NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

    • Stay timely. Submit only on articles published within the last 8 weeks.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • 200 words maximum.
    • 5 references maximum. Reference 1 must be the article on which you are commenting.
    • 5 authors maximum. Exception: replies can include all original authors of the article.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Topics Discussed

    Alert Me